Monashee Investment Management LLC purchased a new position in Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 74,792 shares of the biotechnology company’s stock, valued at approximately $1,426,000. A number of other institutional investors […]
Analysts Set Alpine Immune Sciences, Inc (NASDAQ:ALPN) PT at $22 50 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Alpine Immune Sciences (NASDAQ:ALPN – Free Report) had its price objective boosted by Oppenheimer from $14.00 to $22.00 in a research report released on Monday, MarketBeat reports. Oppenheimer currently has an outperform rating on the biotechnology company’s stock. Several other research firms have also issued reports on ALPN. HC Wainwright restated a buy rating and […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report)’s share price hit a new 52-week high during trading on Tuesday after Wedbush raised their price target on the stock from $17.00 to $19.00. Wedbush currently has an outperform rating on the stock. Alpine Immune Sciences traded as high as $14.92 and last traded at $13.99, […]